CXCR4 and benign prostatic hyperplasia: Immunohistochemical analysis of prostate sections taken from patients with benign disease, localised CaP or bone metastases (Figure 5A) showed that both BPH and localised CaP expressed high levels of CXCR4 within the nucleus.